{"title":"基于固有信号的因果关系和能量学设计结构特异性和可切换的gpcr变构效应。","authors":"Bingxue Dong, Wei-Ven Tee, Igor N Berezovsky","doi":"10.1016/j.jmb.2025.169293","DOIUrl":null,"url":null,"abstract":"<p><p>The pervasiveness and versatility of G protein-coupled receptors (GPCRs) in virtually all physiological processes is based on the receptors' capability to activate intracellular signal transduction pathways in response to diverse extracellular stimuli. While the importance of GPCRs makes them the largest group of drug targets (comprising about one-third of marketed medicines), more than half of GPCRs lack preclinical drug candidates because of high structural conservatism of their orthosteric sites. Recognizing that the mechanisms of GPCR function and regulation are chiefly allosteric in nature, we explore their allosteric control and the potential for developing allosteric drugs with high specificity. First, we obtained a picture of allosteric signaling in 280 non-olfactory GPCRs in human and explored archetypal structure-based patterns and sequence-determined variations of allosteric communication. We showed how the causality of allosteric effects due to ligand binding can be quantified, using the β<sub>2</sub>-adrenergic receptor (ADRB2) and glucagon-like peptide 1 receptor (GLP1R) as case studies. Implementing our directed design protocol for developing allosteric drug candidates, switchable agonist-antagonist pairs were obtained for GPL1R. Moreover, we showed the predictive power of our approach for identification of latent allosteric sites and the capability for de novo design of agonistic and antagonistic effectors. We also performed efficacy-based design of ligands, demonstrating on the homologous GLP1R and GIPR that the strength of allosteric signaling induced by an effector can determine specificity to a target receptor. Our computational framework not only provides a foundation for addressing the problem of \"difficult\" GPCR targets with the allosteric approach, but also allows rational design of effectors with controllable mode switching and high specificity in general. The comprehensive data on allosteric signaling in classes A, B1, B2, C, F, and T GPCRs at single-residue resolution is available in the AlloMAPS database (https://allomaps.bii.a-star.edu.sg/browse/gpcraf).</p>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":" ","pages":"169293"},"PeriodicalIF":4.5000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Designing Structure-specific and Switchable Allosteric Effectors for GPCRs Based on the Causality and Energetics of Inherent Signaling.\",\"authors\":\"Bingxue Dong, Wei-Ven Tee, Igor N Berezovsky\",\"doi\":\"10.1016/j.jmb.2025.169293\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The pervasiveness and versatility of G protein-coupled receptors (GPCRs) in virtually all physiological processes is based on the receptors' capability to activate intracellular signal transduction pathways in response to diverse extracellular stimuli. While the importance of GPCRs makes them the largest group of drug targets (comprising about one-third of marketed medicines), more than half of GPCRs lack preclinical drug candidates because of high structural conservatism of their orthosteric sites. Recognizing that the mechanisms of GPCR function and regulation are chiefly allosteric in nature, we explore their allosteric control and the potential for developing allosteric drugs with high specificity. First, we obtained a picture of allosteric signaling in 280 non-olfactory GPCRs in human and explored archetypal structure-based patterns and sequence-determined variations of allosteric communication. We showed how the causality of allosteric effects due to ligand binding can be quantified, using the β<sub>2</sub>-adrenergic receptor (ADRB2) and glucagon-like peptide 1 receptor (GLP1R) as case studies. Implementing our directed design protocol for developing allosteric drug candidates, switchable agonist-antagonist pairs were obtained for GPL1R. Moreover, we showed the predictive power of our approach for identification of latent allosteric sites and the capability for de novo design of agonistic and antagonistic effectors. We also performed efficacy-based design of ligands, demonstrating on the homologous GLP1R and GIPR that the strength of allosteric signaling induced by an effector can determine specificity to a target receptor. Our computational framework not only provides a foundation for addressing the problem of \\\"difficult\\\" GPCR targets with the allosteric approach, but also allows rational design of effectors with controllable mode switching and high specificity in general. The comprehensive data on allosteric signaling in classes A, B1, B2, C, F, and T GPCRs at single-residue resolution is available in the AlloMAPS database (https://allomaps.bii.a-star.edu.sg/browse/gpcraf).</p>\",\"PeriodicalId\":369,\"journal\":{\"name\":\"Journal of Molecular Biology\",\"volume\":\" \",\"pages\":\"169293\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-06-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Molecular Biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jmb.2025.169293\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.jmb.2025.169293","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Designing Structure-specific and Switchable Allosteric Effectors for GPCRs Based on the Causality and Energetics of Inherent Signaling.
The pervasiveness and versatility of G protein-coupled receptors (GPCRs) in virtually all physiological processes is based on the receptors' capability to activate intracellular signal transduction pathways in response to diverse extracellular stimuli. While the importance of GPCRs makes them the largest group of drug targets (comprising about one-third of marketed medicines), more than half of GPCRs lack preclinical drug candidates because of high structural conservatism of their orthosteric sites. Recognizing that the mechanisms of GPCR function and regulation are chiefly allosteric in nature, we explore their allosteric control and the potential for developing allosteric drugs with high specificity. First, we obtained a picture of allosteric signaling in 280 non-olfactory GPCRs in human and explored archetypal structure-based patterns and sequence-determined variations of allosteric communication. We showed how the causality of allosteric effects due to ligand binding can be quantified, using the β2-adrenergic receptor (ADRB2) and glucagon-like peptide 1 receptor (GLP1R) as case studies. Implementing our directed design protocol for developing allosteric drug candidates, switchable agonist-antagonist pairs were obtained for GPL1R. Moreover, we showed the predictive power of our approach for identification of latent allosteric sites and the capability for de novo design of agonistic and antagonistic effectors. We also performed efficacy-based design of ligands, demonstrating on the homologous GLP1R and GIPR that the strength of allosteric signaling induced by an effector can determine specificity to a target receptor. Our computational framework not only provides a foundation for addressing the problem of "difficult" GPCR targets with the allosteric approach, but also allows rational design of effectors with controllable mode switching and high specificity in general. The comprehensive data on allosteric signaling in classes A, B1, B2, C, F, and T GPCRs at single-residue resolution is available in the AlloMAPS database (https://allomaps.bii.a-star.edu.sg/browse/gpcraf).
期刊介绍:
Journal of Molecular Biology (JMB) provides high quality, comprehensive and broad coverage in all areas of molecular biology. The journal publishes original scientific research papers that provide mechanistic and functional insights and report a significant advance to the field. The journal encourages the submission of multidisciplinary studies that use complementary experimental and computational approaches to address challenging biological questions.
Research areas include but are not limited to: Biomolecular interactions, signaling networks, systems biology; Cell cycle, cell growth, cell differentiation; Cell death, autophagy; Cell signaling and regulation; Chemical biology; Computational biology, in combination with experimental studies; DNA replication, repair, and recombination; Development, regenerative biology, mechanistic and functional studies of stem cells; Epigenetics, chromatin structure and function; Gene expression; Membrane processes, cell surface proteins and cell-cell interactions; Methodological advances, both experimental and theoretical, including databases; Microbiology, virology, and interactions with the host or environment; Microbiota mechanistic and functional studies; Nuclear organization; Post-translational modifications, proteomics; Processing and function of biologically important macromolecules and complexes; Molecular basis of disease; RNA processing, structure and functions of non-coding RNAs, transcription; Sorting, spatiotemporal organization, trafficking; Structural biology; Synthetic biology; Translation, protein folding, chaperones, protein degradation and quality control.